NCT07429552Completed
Dynamic Mixed Learning Module in Pulmonary Hypertension Patients
The Effect of a Dynamic Blended Learning Module on Symptom Management in Patients Diagnosed With Pulmonary Hypertension
Source: ClinicalTrials.gov · Last updated 24 Feb 2026
Brief summary (registry, in English)
This study was conducted to evaluate the effect of the Dynamic Blended Learning Module developed for patients diagnosed with pulmonary hypertension (PH) on symptom management. Pulmonary hypertension is a chronic disease that can cause symptoms that make daily life difficult, such as shortness of breath, fatigue, chest pain, dizziness, fainting, anxiety, body pain, edema, and sleep problems. These symptoms can negatively affect patients' daily lives and treatment process. This study examined whether a structured program involving education and regular follow-up helped patients better manage their symptoms. As part of the program, patients received face-to-face education and regular phone calls were made throughout the nine-month follow-up period. The education sessions provided information about the course of the disease, the correct use of medications, and possible side effects. Patients were instructed on how to manage side effects such as muscle and jaw pain, facial redness, nausea, and abdominal bloating. Additionally, they were informed about when and how to contact the healthcare team if any issues arose. In one part of the program, a video showing the experiences of a patient who effectively managed their illness was shown to participants in the intervention group. Patients were monitored for nine months and their symptoms were assessed at regular intervals. The program's effect on symptom management was evaluated by comparing it with patients receiving standard care.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 49 (actual)
- First submitted
- 14 Aug 2025
- Start date
- 3 Jan 2022
- Primary completion date
- 27 Dec 2023
- Lead sponsor
- Acibadem University
- NCT number
- NCT07429552
What you commit to
- Study type: Interventional
- Participants enrolled: 49
- From 3 Jan 2022 to the primary completion date, 27 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who have previously undergone pulmonary endarterectomy and currently exhibit normal pulmonary artery pressures
Other illness
- Patients with an unstable or acute clinical condition
Other
- Individuals with cognitive impairments or communication difficulties that would interfere with study participation
- Individuals who decline to provide informed consent for participation
Who the study is looking for
- Diagnosis of pulmonary hypertension.
- Functional class I-IV.
- Confirmed diagnosis of pulmonary hypertension for at least 6 months.
- Native Turkish speaker.
- Age ≥18 years
- Voluntary willingness to participate in the study
Age in the registry: 18 years to 85 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Provincial Directorate of Health Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.